Psyllium and Fabrazyme drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Psyllium (blond psyllium) and Fabrazyme (agalsidase beta). Common drug interactions include hyponatraemia among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Psyllium and Fabrazyme. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Psyllium?

Psyllium has active ingredients of blond psyllium. It is often used in constipation. eHealthMe is studying from 4,262 Psyllium users. Check the latest studies of Psyllium.

What is Fabrazyme?

Fabrazyme has active ingredients of agalsidase beta. eHealthMe is studying from 10,406 Fabrazyme users. Check the latest studies of Fabrazyme.

On Jul, 08, 2026

17 people who take Psyllium and Fabrazyme together, and have interactions are studied.

Psyllium and Fabrazyme drug interactions.

What are the common drug interactions of Psyllium and Fabrazyme, by gender? *:

female:

Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Petechiae (a small red or purple spot caused by bleeding into the skin)
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)

male:

Fall
Back pain
Aphasia (damage to the parts of the brain that control language)
Back disorder
Dysarthria (speech disorder)
Incoherent (talking in a confused and unclear way)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
Vision blurred
Balance disorder

What are the common drug interactions of Psyllium and Fabrazyme, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Infection
Acne (skin problems that cause pimples)
Aphasia (damage to the parts of the brain that control language)
Back disorder
Dysarthria (speech disorder)
Incoherent (talking in a confused and unclear way)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
Vision blurred
Balance disorder

50-59:

n/a

60+:

Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Petechiae (a small red or purple spot caused by bleeding into the skin)
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)

What are the existing conditions these people have? *

Fabry's Disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells): 17 people, 100.00%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 9 people, 52.94%
Skin Blushing/flushing (a sudden reddening of the face, neck): 7 people, 41.18%
Lipidosis (disorder of lipid metabolism involving abnormal accumulation of lipids in the reticuloendothelial cells): 5 people, 29.41%
Stress And Anxiety: 1 person, 5.88%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Psyllium and Fabrazyme?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously